首页> 外文期刊>Journal of pharmaceutical health services research: >Poor performance of medicines logistics and supply chain systems in a developing country context: lessons from Nigeria
【24h】

Poor performance of medicines logistics and supply chain systems in a developing country context: lessons from Nigeria

机译:药品物流和供应链系统在发展中国家背景下的表现不佳:尼日利亚的课程

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Objectives Access to affordable quality essential medicines in developing countries like Nigeria continues to be a challenge despite interventions by relevant stakeholders. Inadequate management of the medicines supply chain is a major contributing factor. This study aims at identifying indicators for the poor supply chain management (SCM) for medicines in Nigeria. Methods Quantitative and qualitative data from logistics companies and pharmacists practicing in Nigeria were obtained and analyzed using descriptive statistics and thematic analysis respectively. Key findings Logistics companies are not adequately equipped and no monitoring is in place to ensure that standards are set and followed. About 84% of logistics companies had no set of standard operating procedures for medicines logistics. About 37% are capable of providing cold chain logistics depending on the duration. There was no form of regulation enforcing standards for medicines logistics. Pharmacists’ views suggest that poor logistics and SCM practices, weak regulation and policy implementation and lack of support for in‐country medical logisticians are factors affecting efficient SCM of medicines. Conclusions Indicators for poor SCM of medicines were identified, hence, the need for establishing measures for improvement. Such measures may include more political will in implementing policies, financing SCM of medicines, building in‐country skills and capacity in SCM of medicines, individualizing and segmenting medicines supply chains, and creating a regulatory body for certifying and professionalizing medical logistics companies, logisticians and supply chain managers in Nigeria. These may lead to better access to quality and affordable medicines.
机译:摘要目的,尽管有关利益攸关方的干预措施,但在尼日利亚等发展中国家的经济适用质量基本药物的进入仍然是一项挑战。药物供应链的管理不足是一个主要的贡献因素。本研究旨在识别尼日利亚药物供应链管理(SCM)的指标。方法利用描述性统计和专题分析获得了物流公司和物流公司和药剂师的定量和定性数据,分别使用描述性统计和专题分析分析。主要发现物流公司未充分配备,无法确保设定和遵循标准。约84%的物流公司没有药物物流的标准操作程序。大约37%的人能够根据持续时间提供冷链物流。没有形式的药物物流制定标准。药剂师的观点表明,物流和SCM实践不佳,监管规律和政策实施薄弱,缺乏对国家医疗逻辑的支持,是影响药物高效SCM的因素。结论确定了贫困药物SCM的指标,因此,需要建立改进措施。这些措施可能包括更多政治意愿,在实施政策,融资药物融资,建立国内技能和药物SCM的能力,个性化和分割药物供应链,并创造一个监管机构,用于认证和专业化医疗物流公司,物流公司和尼日利亚供应链管理人员。这些可能导致更好地获得质量和实惠的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号